We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
(-8.1%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-13.95%
Top 10 Holdings %
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$10.9M |
| 2 |
ARNC
Arconic Corporation
ARNC
|
+$7.33M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$7.14M |
| 4 |
NetEase
NTES
|
+$7.01M |
| 5 |
Micron Technology
MU
|
+$6.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$65.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$62.2M |
| 3 |
Li Auto
LI
|
+$29.4M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$15.1M |
| 5 |
Alibaba
BABA
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.1% |
| 2 | Consumer Discretionary | 11.71% |
| 3 | Healthcare | 9.05% |
| 4 | Industrials | 8.79% |
| 5 | Financials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOS
951
CALL
SOS Limited
SOS
$14.6M
| $74.3K | ﹤0.01% |
1,193
| – | – |
|
952
Unisys
UIS
$217M
| $73K | ﹤0.01% |
18,337
-10,961
| -37% | -$43.5K |
|
|
AGS
953
DELISTED
PlayAGS
AGS
| $72.4K | ﹤0.01% |
+12,813
| New | +$74.8K |
|
|
CHS
954
DELISTED
Chicos FAS, Inc.
CHS
| $71.8K | ﹤0.01% |
+13,429
| New | +$70.1K |
|
955
MacroGenics
MGNX
$257M
| $71.6K | ﹤0.01% |
+13,374
| New | +$82.5K |
|
956
Harvard Bioscience
HBIO
$29.2M
| $68.6K | ﹤0.01% |
+1,250
| New | +$68.6K |
|
957
Solid Power
SLDP
$532M
| $68.1K | ﹤0.01% |
+26,800
| New | +$61.8K |
|
|
LTCH
958
DELISTED
Latch, Inc. Common Stock
LTCH
| $67.1K | ﹤0.01% |
+48,292
| New | +$45.1K |
|
959
Telos
TLS
$358M
| $63.6K | ﹤0.01% |
24,830
-2,385
| -9% | -$5.66K |
|
960
Quad
QUAD
$525M
| $62K | ﹤0.01% |
+16,500
| New | +$59.6K |
|
|
RGLS
961
DELISTED
Regulus Therapeutics
RGLS
| $59.8K | ﹤0.01% |
+40,660
| New | +$54.2K |
|
962
Larimar Therapeutics
LRMR
$432M
| $59.5K | ﹤0.01% |
19,013
+6,313
| +50% | +$25.8K |
|
|
NFYS
963
DELISTED
Enphys Acquisition Corp.
NFYS
| $59.1K | ﹤0.01% |
39,063
| – | – |
|
964
Genworth Financial
GNW
$3.71B
| $56.9K | ﹤0.01% |
11,385
+1,385
| +14% | +$7.58K |
|
965
8x8 Inc
EGHT
$332M
| $56.5K | ﹤0.01% |
+13,346
| New | +$48.1K |
|
|
DRRX
966
DELISTED
DURECT Corp
DRRX
| $55.9K | ﹤0.01% |
11,288
-1,254
| -10% | -$6.36K |
|
|
EQRX
967
DELISTED
EQRx, Inc. Common Stock
EQRX
| $55.6K | ﹤0.01% |
29,900
| – | – |
|
|
ROVR
968
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $55.5K | ﹤0.01% |
+11,300
| New | +$51.7K |
|
969
Mammoth Energy Services
TUSK
$163M
| $50.2K | ﹤0.01% |
+10,403
| New | +$43.1K |
|
970
LivePerson
LPSN
$32.3M
| $49.7K | ﹤0.01% |
732
+16
| +2% | +$1.04K |
|
971
BioAtla
BCAB
$5.74M
| $48K | ﹤0.01% |
320
+63
| +25% | +$10.8K |
|
|
TRML
972
DELISTED
Tourmaline Bio
TRML
| $47.8K | ﹤0.01% |
+1,573
| New | +$40.2K |
|
973
Entravision Communication
EVC
$1.1B
| $47.4K | ﹤0.01% |
+10,800
| New | +$55K |
|
974
Relmada Therapeutics
RLMD
$527M
| $45.8K | ﹤0.01% |
18,600
+1,900
| +11% | +$5.25K |
|
|
KYNB
975
Kyntra Bio
KYNB
$29.4M
| $45.7K | ﹤0.01% |
+677
| New | +$280K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.
- Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
- Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
- Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
- Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
- Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
- Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
- Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.
Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.